Probiotics Against Viruses; COVID-19 is a Paper Tiger: A Systematic Review.
Endocr Metab Immune Disord Drug Targets
; 21(7): 1252-1260, 2021.
Article
in English
| MEDLINE | ID: covidwho-771651
ABSTRACT
BACKGROUND:
Probiotics can improve immune function leading to the prevention and management of viral infections like SARS-CoV-2 infection (COVID-19 disease).METHODS:
We searched PubMed, EMBASE, Google Scholar, Science Direct, Scopus, and Web of Science up to May 2020 to identify interventional & observational studies documenting the effects of probiotics on incidence, severity, duration, and other clinical manifestations of viral infections, especially SARS-CoV-2-induced.RESULTS:
From a total of 91 records, 24 studies were obtained and classified into three domains based on the efficacy of probiotics on 1) shortening the period and severity of infections (n=9), 2) incidence (n=6), and 3) other clinical complications that may be followed by viral disorders (n=9). Identified probiotics have positive effects on the mentioned domains.CONCLUSION:
Based on the evidence, some probiotic strains may be useful in SARS-CoV-2 infection; randomized trials are needed to show the facts.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Probiotics
/
SARS-CoV-2
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
/
Randomized controlled trials
/
Reviews
/
Systematic review/Meta Analysis
Limits:
Animals
/
Humans
Language:
English
Journal:
Endocr Metab Immune Disord Drug Targets
Journal subject:
Allergy and Immunology
/
Endocrinology
/
Metabolism
/
Drug Therapy
Year:
2021
Document Type:
Article
Affiliation country:
1871530320666200917114033
Similar
MEDLINE
...
LILACS
LIS